Literature DB >> 25887823

Open Versus Arthroscopic Reduction for Tibial Eminence Fracture Fixation in Children.

Chad D Watts1, A Noelle Larson, Todd A Milbrandt.   

Abstract

BACKGROUND: Stiffness is a common complication following surgically treated tibial eminence fractures. Fractures can be addressed with either open reduction and internal fixation (ORIF) or arthroscopic reduction and internal fixation (ARIF). We sought to evaluate the effects of surgical approach and other modifiable perioperative factors on postoperative arthrofibrosis. We hypothesized that ARIF would result in a lower risk of arthrofibrosis.
METHODS: We retrospectively reviewed the records of all patients aged 18 years and below treated for tibial eminence fractures at our institution from 1998 to 2014. All patients were treated by either pediatric or sports fellowship-trained orthopaedic surgeons and followed until radiographic union and return of range of motion or treatment for arthrofibrosis (minimum 3 mo).
RESULTS: Thirty-one patients were included in our analysis, 13 in the ORIF group and 18 in the ARIF group. The groups were similar in regards to sex, age, fracture type, fixation method, and length of postoperative immobilization. However, when compared with the ORIF group, patients in the ARIF group had significantly longer time from injury to surgery (4.2 vs. 6.3 d, P=0.03), operative time (98 vs. 141 min, P=0.02), and tourniquet time (76 vs. 100 min, P=0.006). In the ARIF group, 6 (33.3%) patients acquired arthrofibrosis compared with only 1 (7.7%) patient in the ORIF group. Delaying surgery ≥7 days from injury [hazard ratio (HR)=4.7, P=0.04] and operative time ≥120 minutes (HR=9.1, P=0.03) were risk factors for arthrofibrosis. ARIF was a risk factor in univariate (HR=4.0, P=0.04), but not in multivariate (1.4, P=0.77) analysis.
CONCLUSIONS: Delayed surgery (≥7 d from injury) and prolonged operative times (≥120 min) were significant risk factors for arthrofibrosis. Although ARIF was not an independent risk factor, these patients were exposed to markedly longer wait times before surgery and operative times when compared with ORIF patients. ORIF is a reasonable option for treatment of displaced tibial eminence fractures. Surgeons should approach tibial eminence fractures with whichever mode they can accomplish with higher efficiency. LEVEL OF EVIDENCE: Level III-therapeutic study.

Entities:  

Mesh:

Year:  2016        PMID: 25887823     DOI: 10.1097/BPO.0000000000000476

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  12 in total

1.  Absorbable and non-absorbable suture fixation results in similar outcomes for tibial eminence fractures in children and adolescents.

Authors:  Stefan Brunner; Patrick Vavken; Robert Kilger; Julia Vavken; Erich Rutz; Reinald Brunner; Carlo Camathias
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-10-31       Impact factor: 4.342

Review 2.  Arthroscopic treatment of tibial eminence fracture: a systematic review of different fixation methods.

Authors:  Leonardo Osti; Matteo Buda; Francesco Soldati; Angelo Del Buono; Raffaella Osti; Nicola Maffulli
Journal:  Br Med Bull       Date:  2016-05-05       Impact factor: 4.291

3.  Reliable ligamentous stability and high return-to-sport rates after arthroscopic reduction and internal fixation of tibial eminence fractures.

Authors:  Patricia M Lutz; Stephanie Geyer; Philipp W Winkler; Markus Irger; Daniel P Berthold; Matthias J Feucht; Andreas B Imhoff; Philipp Forkel
Journal:  Arch Orthop Trauma Surg       Date:  2021-05-19       Impact factor: 3.067

4.  Arthroscopic tri-pulley Technology reduction and internal fixation of pediatric Tibial Eminence fracture: a retrospective analysis.

Authors:  Liang Zhang; Li Zhang; Jiang Zheng; Bo Ren; Xin Kang; Xian Zhang; Xiaoqian Dang
Journal:  BMC Musculoskelet Disord       Date:  2020-06-29       Impact factor: 2.362

5.  Arthroscopic Fixation for Tibial Eminence Fractures: Comparison of Double-Row and Transosseous Anchor Knot Fixation Techniques with Suture Anchors.

Authors:  Ji Li; Chuihui Liu; Zhongli Li; Yangmu Fu; Yimeng Yang; Qiang Zhang
Journal:  Med Sci Monit       Date:  2018-10-15

6.  Pediatric Type II Tibial Spine Fractures: Addressing the Treatment Controversy With a Mixed-Effects Model.

Authors:  Alexander J Adams; Nathan N O'Hara; Joshua M Abzug; Julien T Aoyama; Theodore J Ganley; James L Carey; Aristides I Cruz; Henry B Ellis; Peter D Fabricant; Daniel W Green; Benton E Heyworth; Joseph A Janicki; Mininder S Kocher; John T R Lawrence; R Jay Lee; Scott D McKay; R Justin Mistovich; Neeraj M Patel; John D Polousky; Jason T Rhodes; Brant C Sachleben; M Catherine Sargent; Gregory A Schmale; Kevin G Shea; Yi-Meng Yen
Journal:  Orthop J Sports Med       Date:  2019-08-28

7.  A Comparison of Nonoperative and Operative Treatment of Type 2 Tibial Spine Fractures.

Authors:  Niyathi Prasad; Julien T Aoyama; Theodore J Ganley; Henry B Ellis; R Justin Mistovich; Yi-Meng Yen; Peter D Fabricant; Daniel W Green; Aristides I Cruz; Scott McKay; Indranil Kushare; Gregory A Schmale; Jason T Rhodes; Jason Jagodzinski; Brant C Sachleben; M Catherine Sargent; R Jay Lee
Journal:  Orthop J Sports Med       Date:  2021-01-22

8.  Preliminary clinical outcomes of the double-row anchor suture-bridge technique for the fixation of tibial intercondylar eminence fractures in adults: a 12-months minimal follow-up.

Authors:  Yupeng Chu; Ting Hu; Mangmang Chen; Chendi Jiang; Zhuqi Wu; Junwu Shi
Journal:  BMC Musculoskelet Disord       Date:  2021-01-13       Impact factor: 2.362

9.  Effect of Skeletal Maturity on Fixation Techniques for Tibial Eminence Fractures.

Authors:  Andrew P Thome; Ryan O'Donnell; Steven F DeFroda; Brian H Cohen; Aristides I Cruz; Braden C Fleming; Brett D Owens
Journal:  Orthop J Sports Med       Date:  2021-11-12

10.  Pediatric tibial eminence fracture treatment: A case series using a bioabsorbable screw.

Authors:  M Wesley Honeycutt; Anna J Rambo; Daniel P Zieman; Prasit Nimityongskul
Journal:  J Clin Orthop Trauma       Date:  2020-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.